FDA device listing
ADVIA Centaur EBV-EBNA IgG,ADVIA Centaur EBV-EBNA IgG Quality Control
FDA device listing 1703744455 · BIOKIT S.A.
Key facts
| Proprietary names | ADVIA Centaur EBV-EBNA IgG,ADVIA Centaur EBV-EBNA IgG Quality Control |
|---|---|
| Owner/operator | BIOKIT S.A. |
| Owner/operator number | 8030752 |
| Product codes | LLM, LSE |
| Device names | LLM - Test, Antigen, Nuclear, Epstein-Barr Virus, LSE - Epstein-Barr Virus, Other |
| Device class | Class I |
| Classification regulations (21 CFR) | 866.3235 |
| Review panels | Microbiology |
| Registered establishments | BIOKIT S.A. |
| Establishment registrations | 9610746 |
| FEI numbers | 3002806557 |
| Establishment operations | Contract Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database